Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells
By T. Kanzawa, I. Germano, T. Komata, Hideaki Ito, Y. Kondo, Seiji Kondo. Cell Death and Differentiation, 2004
1,019 citations recorded by the source corpus.
Subfields: Cell Biology, Epidemiology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/d657fa4b7924faa3af743a719d1e6a67872bea1e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cell Biology
In Epidemiology
- Guido Kroemer
- N. Mizushima
- Beth Levine
- D. Klionsky
- A. Cuervo
- Ralph A. Nixon
- Craig B. Thompson
- I. Slaninová
In Molecular Biology
Citations in the corpus
- LC3 conjugation system in mammalian autophagy (2004, background): “Treatment of glioma cell cultures with TMZ (5-1000 M) was found to inhibit cell viability and increase the number of LC3-positive autophagic vacuoles, showing that TMZ stimulates autophagy in glioma cells (Kanzawa et al., 2004).”
- Autophagy and autophagy-related proteins in cancer (2020, background): “lignant glioma cells [260, 261], Temozolomide (TMZ) in malignant glioma cells [262], γ-irradiation in breast cancer, prostate cancer, colon cancer and malignant glioma [263–265], resveratrol in ovarian cancer [266], TNFα in breast cancer cells [267], IFNγ in Hepatocellular carcinoma (HCC) [268], ima”
- Inhibition of Macroautophagy Triggers Apoptosis (2005, background): “For example, type 2 cell death affects degenerating neurons in some pathologies (17, 39), participates in retinal degeneration (24), seals the fate of Salmonella-infected macrophages (26), and sometimes mediates chemotherapy-induced tumor killing (30, 31, 55).”
- Macroautophagy—a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease (2005, background): “stress, exposure to toxins (Kanzawa et al., 2004), or dysfunc-”
- Growth factor regulation of autophagy and cell survival in the absence of apoptosis. (2005, background): “Elimination of extracellular factors on which cells depend to maintain anapleurotictherapy drugs (Daido et al., 2004; Kanzawa et al., 2004; Paglin et al., 2001; Talloczy et al., 2002).”